达嘉维康

Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd. is a prominent Chinese healthcare enterprise specializing in pharmaceutical distribution, retail pharmacy, and medical services. Headquartered in Changsha, the company operates a robust distribution network and a chain of specialty pharmacies that focus on high-value medications for oncology, immunology, and rare diseases. Dajia Weikang has vertically integrated its operations by establishing medical institutions, such as reproductive medicine hospitals, and maintaining manufacturing capabilities for chemical drugs and Traditional Chinese Medicine. Publicly traded on the Shenzhen Stock Exchange, the company serves as a key regional player in the pharmaceutical supply chain within Hunan Province. The company is particularly recognized for its Direct-to-Patient (DTP) pharmacy model, which facilitates the delivery of innovative and complex therapies directly to consumers.